Application of sequential factorial design and orthogonal array composite design (OACD) to study combination of 5 prostate cancer drugs

The anti-malarial artesunate is also active against cancer

Thomas Efferth, Heather M. Dunstan, Axel Sauerbrey et al. · International Journal of Oncology · 2001 · 568 citations

Oncology, Antiparasitic Agent, Medicine +10

Multinational, Double-Blind, Phase III Study of Prednisone and Either Satraplatin or Placebo in Patients With Castrate-Refractory Prostate Cancer Progressing After Prior Chemotherapy: The SPARC Trial

Cora N. Sternberg, Daniel P. Petrylak, Oliver Sartor et al. · Journal of Clinical Oncology · 2009 · 339 citations · Full text

An optimized small molecule inhibitor cocktail supports long-term maintenance of human embryonic stem cells

Hideaki Tsutsui, Bahram Valamehr, Antreas Hindoyan et al. · Nature Communications · 2011 · 172 citations · Full text

Regenerative Medicine, Induced Pluripotent Stem Cell, Long-term Maintenance +10

Transferrin receptor-dependent cytotoxicity of artemisinin–transferrin conjugates on prostate cancer cells and induction of apoptosis

Ikuhiko Nakase, Byron Gallis, Tomoka Takatani‐Nakase et al. · Cancer Letters · 2008 · 135 citations

Medicine, Apoptosis, Cell Death +9

Anticancer and Antimalarial Efficacy and Safety of Artemisinin-Derived Trioxane Dimers in Rodents

Gary H. Posner, Andrew J. McRiner, Ik‐Hyeon Paik et al. · Journal of Medicinal Chemistry · 2004 · 119 citations